SCHEMBL968012

SCHEMBL968012

Cc1c(C(=O)O)cccc1-c1nnc(-c2ccc(-c3nnc(-c4ccc(C(C)(C)C)cc4)o3)cc2)o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.56
ALDH1A1 P00352 5/20 0.53
KDM4E B2RXH2 4/20 0.53
MAPT P10636 3/20 0.53
NR1H4 Q96RI1 2/20 0.50
TP53 P04637 1/20 0.50
S1PR4 O95977 1/20 0.49
S1PR5 Q9H228 1/20 0.49
RAB9A P51151 6/20 0.47
NPC1 O15118 5/20 0.47
SMN1; SMN2 Q16637 5/20 0.44
HPGD P15428 4/20 0.44
TSHR P16473 2/20 0.44
PPARG P37231 1/20 0.44
POLB P06746 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TRPV1 Q8NER1 1/20 0.43
EGFR P00533 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206430 0.88 S1PR1 (0.64) S1PR1ALDH1A1KDM4EMAPTNR1H4
SCHEMBL20504191 0.83 NR1H4 (0.52) ALDH1A1KDM4ENR1H4RAB9ANPC1
SCHEMBL3722422 0.82 NPC1 (0.50) S1PR1ALDH1A1KDM4EMAPTNR1H4
SCHEMBL30297003 0.79 S1PR1 (0.79) S1PR1ALDH1A1KDM4EMAPTTP53
SCHEMBL1999483 0.79 S1PR1 (0.79) S1PR1ALDH1A1KDM4EMAPTTP53
SCHEMBL5204926 0.79 S1PR1 (0.59) S1PR1ALDH1A1KDM4EMAPTNR1H4
SCHEMBL5206623 0.78 NPC1 (0.68) S1PR1ALDH1A1KDM4EMAPTNR1H4
SCHEMBL21760737 0.76 NPC1 (0.66) S1PR1KDM4ENR1H4S1PR4S1PR5
SCHEMBL2785369 0.76 S1PR1 (0.71) S1PR1ALDH1A1KDM4EMAPTNR1H4
SCHEMBL968770 0.76 NPC1 (0.66) S1PR1ALDH1A1KDM4EMAPTNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009584-A1 Romp-Polymerizable Electron Transport Materials Based On A Bis-Oxadiazole Moiety GEORGIA TECH RESEARCH CORPORATION (US) 2011-01-13 US disclosed
EP-2234991-A1 ROMP-POLYMERIZABLE ELECTRON TRANSPORT MATERIALS BASED ON A BIS-OXADIAZOLE MOIETY Georgia Tech Research Corporation (US) 2010-10-06 EP disclosed
WO-2009080797-A1 ROMP-POLYMERIZABLE ELECTRON TRANSPORT MATERIALS BASED ON A BIS-OXADIAZOLE MOIETY GEORGIA TECH RESEARCH CORPORATION (US) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009584-A1 Romp-Polymerizable Electron Transport Materials Based On A Bis-Oxadiazole Moiety SLCO1B3, SLCO4C1, SLCO2B1 S1PR1 4412/4885ALDH1A1 1377/4885KDM4E 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.